# Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study

> **NCT02581176** · PHASE4 · COMPLETED · sponsor: **University Hospital, Akershus** · enrollment: 300 (actual)

## Conditions studied

- Neoplasms
- Venous Thrombosis

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT02581176
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2018-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02581176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02581176, "Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02581176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*